Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that it submitted schedule of investor meeting that the Company would be participating as on 20 November 2025.
The above information is a part of company’s filings submitted to BSE.